BioSpace News Archive

Business

Armonica Announces Appointment of Emily Milsovic as CEO

Armonica, a pioneer in optical epigenetic sequencing has appointed Emily Milsovic as its new chief executive officer, effective immediately.

May 29, 2024
·
3 min read
BioMidwest

Zura Bio Announces Participation in June 2024 Investor Conferences

Zura Bio Limited, a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, announced that members of senior management will participate in two investor conferences in June.

May 29, 2024
·
1 min read
Genetown

Nuvalent to Participate in the 2024 Jefferies Global Healthcare Conference

Nuvalent, Inc. announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participate in a fireside chat during the 2024 Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 4:30 p.m. ET in NYC.

May 29, 2024
·
1 min read
Deals

Merck to Acquire EyeBio

Merck, known as MSD outside of the United States and Canada, and Eyebiotech Limited, a privately held ophthalmology-focused biotechnology company, announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire EyeBio.

May 29, 2024
·
9 min read
Biotech Bay

Nurix Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference

Nurix Therapeutics, Inc. announced that Arthur T. Sands, M.D., Ph.D., president and chief executive officer of Nurix, will present a corporate update at the Jefferies Global Healthcare Conference, at 5:30 p.m. ET on Wednesday, June 5, 2024, in New York City.

May 29, 2024
·
1 min read
Pharm Country

Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024

Axsome Therapeutics, Inc. announced five presentations, including two featured oral plenary presentations, on solriamfetol at SLEEP 2024, the 38th annual meeting of the American Academy of Sleep Medicine and the Sleep Research Society, being held June 1-5, 2024, in Houston, Texas.

May 29, 2024
·
6 min read
Business

Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors

Zentalis® Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, announced the appointment of Luke Walker, M.D., to its Board of Directors.

May 29, 2024
·
6 min read
Business

BerGenBio First Quarter Results 2024: Advancing to the Next Stage of Development

BerGenBio ASA, a clinical-stage bio-pharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, announced financial results for the quarter ended March 31, 2024, and provided a business update.

May 29, 2024
·
3 min read
Policy

Beckman Coulter Secures FDA Clearance for Heart Failure Assay on DxI 9000 Immunoassay Analyzer

Beckman Coulter, a global leader in clinical diagnostics, announced U.S. Food and Drug Administration clearance of its Access NT-proBNP assay for the assessment of heart failure in less than 11 minutes on the Beckman Coulter DxI 9000 Immunoassay Analyzer*.

May 29, 2024
·
3 min read
Genetown

Spyre Therapeutics to Participate in the Jefferies Global Healthcare Conference

Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”) today announced that management will participate in a fireside chat and investor meetings at the Jefferies Global Healthcare Conference.

May 29, 2024
·
1 min read